Clinical Trial News Archive - March 2017
Get news by email or subscribe to our news feeds.
March 1, 2017
- SELLAS Life Sciences Announces Updated Positive Phase 2 Data Reinforcing Meaningful Clinical Benefit of its WT1 Immunotherapeutic Anti-cancer Treatment in Multiple Myeloma Patients
- Myovant Sciences Initiates Phase 3 Clinical Trial of Relugolix in Men with Advanced Prostate Cancer
March 2, 2017
March 3, 2017
March 4, 2017
March 6, 2017
March 8, 2017
- Menlo Therapeutics Announces Successful Pruritus Reduction Results from Phase 2 Serlopitant Trial (TCP-102) in 127 Subjects With Prurigo Nodularis
- Ocera to Announce Additional Encouraging Results from its Phase 2b STOP-HE Study of IV OCR-002 in Patients with Hepatic Encephalopathy
March 9, 2017
- Servier and Pfizer Announce FDA Clearance of IND Application for UCART19 in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia
- FDA Grants Orphan Drug Designation to Boehringer Ingelheim’s Investigational Anti-CD33 Monoclonal Antibody BI 836858 for Treatment of Myelodysplastic Syndromes
March 15, 2017
- BriaCell Receives FDA Clearance to Initiate Phase I/IIa Clinical Trial of BriaVax in Patients with Advanced Breast Cancer
- Immunomedics Announces Publication of Results in Journal of Clinical Oncology, Demonstrating Treatment With Sacituzumab Govitecan (IMMU-132) Produces Early and Durable Responses in Patients With Metastatic Triple-Negative Breast Cancer
March 20, 2017
March 21, 2017
March 22, 2017
- Novartis Provides Update on Phase III study of RLX030 (serelaxin) in Patients with Acute Heart Failure
- New England Journal of Medicine Publishes Pivotal Phase III Data for CSL Behring’s Subcutaneous C1-Esterase Inhibitor CSL830 in HAE Patients
- Moleculin Receives Orphan Drug Designation for Annamycin for the Treatment of Acute Myeloid Leukemia
March 27, 2017
- Nektar Therapeutics Initiates Clinical Study of NKTR-358, a First-in-Class Regulatory T Cell Stimulator, Being Developed for the Treatment of Immune and Inflammatory Disorders
- Allergan and Paratek Announce Positive Results From Two Phase 3 Trials of Sarecycline for the Treatment of Moderate to Severe Acne
- Matinas BioPharma Reports Positive Topline Data from Phase 1 Study of MAT2501
March 28, 2017
- Tonix Pharmaceuticals Enrolls First Participant in Military-Related PTSD Phase 3 Trial of FDA Breakthrough Therapy-Designated TNX-102 SL
- Two Phase 3 Studies of the Tezacaftor/Ivacaftor Combination Treatment Met Primary Endpoints with Statistically Significant Improvements in Lung Function (FEV1) in People with Cystic Fibrosis
- Athenex Announces the US FDA Allowance of the Investigational New Drug Application of Oratopo, A Combination of HM30181A and Oral Topotecan For the Treatment of Advanced Cancer
March 30, 2017
- Corbus Pharmaceuticals Reports Positive Topline Data Demonstrating Anabasum Reduces Acute Pulmonary Exacerbations and Multiple Inflammatory Biomarkers in Phase 2 Study in Patients with Cystic Fibrosis
- Aura Biosciences Announces Initiation of Phase 1b Clinical Trial and Receipt of FDA Fast Track Designation for AU-011 for the Treatment of Primary Ocular Melanoma
- Progenics Pharmaceuticals Announces Positive Topline Results from Registrational Phase 2b Trial of Azedra
March 31, 2017
Clinical Trial Results Archive
2018January, February, March, April, May, June, July, August, September, October
2017January, February, March, April, May, June, July, August, September, October, November, December
2016January, February, March, April, May, June, July, August, September, October, November, December
2015January, February, March, April, May, June, July, August, September, October, November, December
2014January, February, March, April, May, June, July, August, September, October, November, December
2013January, February, March, April, May, June, July, August, September, October, November, December
2012January, February, March, April, May, June, July, August, September, October, November, December
2011January, February, March, April, May, June, July, August, September, October, November, December
2010January, February, March, April, May, June, July, August, September, October, November, December
2009January, February, March, April, May, June, July, August, September, October, November, December
2008January, February, March, April, May, June, July, August, September, October, November, December
2007January, February, March, April, May, June, July, August, September, October, November, December
2006December
2005April
2004January, June, July, October
2003November
